Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings

A new Med by Cell Press study from Elif Oral, MD addresses the question of whether Leptin has a role in the development of nonalcoholic steatohepatitis, or NASH, and whether supplementing the protein can be a therapy for patients.